Spots Global Cancer Trial Database for fluorescent antibody technique
Every month we try and update this database with for fluorescent antibody technique cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313 | NCT00896727 | Breast Cancer | gene expression... protein express... fluorescent ant... laboratory biom... | 18 Years - | SWOG Cancer Research Network | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results | NCT00004091 | Cervical Cancer | Papanicolaou te... cytology specim... fluorescent ant... colposcopic bio... study of high r... | - | Northwestern University | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17 | NCT00897065 | Breast Cancer | microarray anal... polymerase chai... protein express... diagnostic labo... fluorescent ant... immunohistochem... immunologic tec... | - | National Cancer Institute (NCI) | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
